Cargando…
Inhibition of 14-3-3/Tau by Hybrid Small-Molecule Peptides Operating via Two Different Binding Modes
[Image: see text] Current molecular hypotheses have not yet delivered marketable treatments for Alzheimer’s disease (AD), arguably due to a lack of understanding of AD biology and an overreliance on conventional drug modalities. Protein–protein interactions (PPIs) are emerging drug targets, which sh...
Autores principales: | Andrei, Sebastian A., Meijer, Femke A., Neves, João Filipe, Brunsveld, Luc, Landrieu, Isabelle, Ottmann, Christian, Milroy, Lech-Gustav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256345/ https://www.ncbi.nlm.nih.gov/pubmed/29722962 http://dx.doi.org/10.1021/acschemneuro.8b00118 |
Ejemplares similares
-
A Binary Bivalent Supramolecular Assembly Platform Based on Cucurbit[8]uril and Dimeric Adapter Protein 14‐3‐3
por: de Vink, Pim J., et al.
Publicado: (2017) -
Selectivity
via Cooperativity: Preferential Stabilization
of the p65/14-3-3 Interaction with Semisynthetic Natural Products
por: Wolter, Madita, et al.
Publicado: (2020) -
Cooperativity basis for small-molecule stabilization of protein–protein interactions
por: de Vink, Pim J., et al.
Publicado: (2019) -
Supramolecular
Chemistry Targeting Proteins
por: van Dun, Sam, et al.
Publicado: (2017) -
Ligand Dependent Switch from RXR Homo- to RXR-NURR1
Heterodimerization
por: Scheepstra, Marcel, et al.
Publicado: (2017)